Biotech Acquisition Co. Prices $40M IPO
Biotech blank check company CB Pharma Acquisition Corp. has priced at $10 per share, making for a $40 million initial public offering as it hopes to tap into the specialty pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article